Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resumption of Antiplatelet Therapy after Major Bleeding.
Geisler T, Poli S, Huber K, Rath D, Aidery P, Kristensen SD, Storey RF, Ball A, Collet JP, Berg JT. Geisler T, et al. Among authors: storey rf. Thromb Haemost. 2023 Feb;123(2):135-149. doi: 10.1055/s-0042-1750419. Epub 2022 Jul 4. Thromb Haemost. 2023. PMID: 35785817 Free article.
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
APPRAISE Steering Committee and Investigators; Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo W, Verheugt F, Wallentin L. APPRAISE Steering Committee and Investigators, et al. Circulation. 2009 Jun 9;119(22):2877-85. doi: 10.1161/CIRCULATIONAHA.108.832139. Epub 2009 May 26. Circulation. 2009. PMID: 19470889 Clinical Trial.
Antiplatelet agents for the treatment and prevention of atherothrombosis.
Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R, Gulba D, Huber K, Husted S, Kristensen SD, Morais J, Neumann FJ, Rasmussen LH, Siegbahn A, Steg PG, Storey RF, Van de Werf F, Verheugt F. Patrono C, et al. Among authors: storey rf. Eur Heart J. 2011 Dec;32(23):2922-32. doi: 10.1093/eurheartj/ehr373. Epub 2011 Oct 20. Eur Heart J. 2011. PMID: 22019823 Review.
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
Agewall S, Cattaneo M, Collet JP, Andreotti F, Lip GY, Verheugt FW, Huber K, Grove EL, Morais J, Husted S, Wassmann S, Rosano G, Atar D, Pathak A, Kjeldsen K, Storey RF; ESC Working Group on Cardiovascular Pharmacology and Drug Therapy and ESC Working Group on Thrombosis. Agewall S, et al. Among authors: storey rf. Eur Heart J. 2013 Jun;34(23):1708-13, 1713a-1713b. doi: 10.1093/eurheartj/eht042. Epub 2013 Feb 20. Eur Heart J. 2013. PMID: 23425521 Review. No abstract available.
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.
Aradi D, Storey RF, Komócsi A, Trenk D, Gulba D, Kiss RG, Husted S, Bonello L, Sibbing D, Collet JP, Huber K; Working Group on Thrombosis of the European Society of Cardiology. Aradi D, et al. Among authors: storey rf. Eur Heart J. 2014 Jan;35(4):209-15. doi: 10.1093/eurheartj/eht375. Epub 2013 Sep 25. Eur Heart J. 2014. PMID: 24067509 Free PMC article. No abstract available.
Response variability to P2Y12 receptor inhibitors: expectations and reality.
Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; EPA (European Platelet Academy). Siller-Matula JM, et al. Among authors: storey rf. JACC Cardiovasc Interv. 2013 Nov;6(11):1111-28. doi: 10.1016/j.jcin.2013.06.011. JACC Cardiovasc Interv. 2013. PMID: 24262612 Free article. Review.
Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy.
Storey RF, Kotha J, Smyth SS, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Storey RF, et al. Thromb Haemost. 2014 May 5;111(5):883-91. doi: 10.1160/TH13-07-0624. Epub 2014 Jan 9. Thromb Haemost. 2014. PMID: 24402559 Clinical Trial.
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel.
Husted S, de Caterina R, Andreotti F, Arnesen H, Bachmann F, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Storey RF, Weitz JI; ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease. Husted S, et al. Among authors: storey rf. Thromb Haemost. 2014 May 5;111(5):781-2. doi: 10.1160/TH14-03-0228. Epub 2014 Mar 21. Thromb Haemost. 2014. PMID: 24658395 No abstract available.
410 results